While mutations in JPH1 are generally not associated with significant muscle diseases in humans, possibly due to the compensatory effect of the concurrent expression of JPH2 in skeletal muscle, numerous point mutations in JPH2 have been identified in patients with cardiomyopathies. The gene discussed is JPH2; the disease is cardiomyopathy.